China · Artificial Intelligence (AI) startup
China · Xbiome
Xbiome is a developer of microbial pharmaceuticals designed to treat microecological intestinal disorders.
Funding reportedLast round: Series B
What company datasets say Xbiome raised
Funding, as reported
Reported in all124.2Min the source's currency
Rounds4
Last roundSeries B
Last round dateDec 2021
Investors listed12
Artificial Intelligence (AI) in China
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Xbiome in front of investors. Or tell us what we have wrong.